13F

ARAY ACCURAY INC

2026Q1 · CUSIP 004397105 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
124
Δ holders QoQ
-1
Breadth percentile
Top 66%
Whale holders
72
Δ whales
-3
Inst. holding value
$221M
New positions
30
Closed positions
31
Price momentum (1Q)
Put / Call
1/0

Breadth history (34 quarters)

2018Q1: Δ+12 · h=126 2018Q2: Δ-5 · h=121 2018Q3: Δ+4 · h=125 2018Q4: Δ+15 · h=140 2019Q1: Δ-3 · h=137 2019Q2: Δ-11 · h=126 2019Q3: Δ-8 · h=118 2019Q4: Δ+4 · h=122 2020Q1: Δ-7 · h=115 2020Q2: Δ+7 · h=122 2020Q3: Δ-4 · h=118 2020Q4: Δ+9 · h=127 2021Q1: Δ+11 · h=138 2021Q2: Δ-4 · h=134 2021Q3: Δ+0 · h=134 2021Q4: Δ+9 · h=143 2022Q1: Δ+0 · h=143 2022Q2: Δ-20 · h=123 2022Q3: Δ-16 · h=107 2022Q4: Δ+2 · h=109 2023Q1: Δ+6 · h=115 2023Q2: Δ+2 · h=117 2023Q3: Δ-2 · h=115 2023Q4: Δ+13 · h=128 2024Q1: Δ-10 · h=118 2024Q2: Δ-2 · h=116 2024Q3: Δ+11 · h=127 2024Q4: Δ+6 · h=133 2025Q1: Δ-4 · h=129 2025Q2: Δ-2 · h=127 2025Q3: Δ+2 · h=129 2025Q4: Δ-4 · h=125 2026Q1: Δ-1 · h=124 2018Q1: holders=126 2018Q2: holders=121 2018Q3: holders=125 2018Q4: holders=140 2019Q1: holders=137 2019Q2: holders=126 2019Q3: holders=118 2019Q4: holders=122 2020Q1: holders=115 2020Q2: holders=122 2020Q3: holders=118 2020Q4: holders=127 2021Q1: holders=138 2021Q2: holders=134 2021Q3: holders=134 2021Q4: holders=143 2022Q1: holders=143 2022Q2: holders=123 2022Q3: holders=107 2022Q4: holders=109 2023Q1: holders=115 2023Q2: holders=117 2023Q3: holders=115 2023Q4: holders=128 2024Q1: holders=118 2024Q2: holders=116 2024Q3: holders=127 2024Q4: holders=133 2025Q1: holders=129 2025Q2: holders=127 2025Q3: holders=129 2025Q4: holders=125 2026Q1: holders=124 -20 -10 +0 +10 +20 96124151 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2018Q4 Top 15% -24.1% -45.3%
2018Q1 Top 19% -28.0% -6.3%

Options Sentiment

Put holders
1
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.37
EPS YoY
Revenue (TTM)
$0.4B
Revenue YoY
-7.9%
Quarterly Revenue & EPS (4Y)
2022-06-30: $110M 2022-09-30: $96M 2022-12-31: $115M 2023-03-31: $118M 2023-06-30: $118M 2023-09-30: $104M 2023-12-31: $107M 2024-03-31: $101M 2024-06-30: $134M 2024-09-30: $102M 2024-12-31: $116M 2025-03-31: $113M 2025-06-30: $128M 2025-09-30: $94M 2025-12-31: $102M 2026-03-31: $105M 2022-06-30: EPS -0.04 2022-09-30: EPS -0.06 2022-12-31: EPS -0.02 2023-03-31: EPS 0.01 2023-06-30: EPS -0.03 2023-09-30: EPS -0.03 2023-12-31: EPS -0.10 2024-03-31: EPS -0.06 2024-06-30: EPS 0.03 2024-09-30: EPS -0.04 2024-12-31: EPS 0.02 2025-03-31: EPS -0.01 2025-06-30: EPS 0.01 2025-09-30: EPS -0.18 2025-12-31: EPS -0.11 2026-03-31: EPS -0.09 0M 67M 134M $M -0.20 -0.08 0.03 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)